Montelukast sodium in preventing oxygen requirements at day 28 in preterm infants: A multicenter randomized controlled trial
Background Evaluating the efficacy and safety of oral montelukast in preventing oxygen requirement at day 28 of birth in preterm infants admitted to the neonatal intensive care unit through a randomized trial with open-label treatment administration and blinded outcome assessment. Methods Target Population: 92 preterm infants admitted to the Neonatal Intensive Care Units of four hospitals. Intervention: Daily oral administration of 1 mg/kg montelukast. Primary Outcome: Incidence of Oxygen requirement on days 14 and 28 of life. Results Reduction in Oxygen requirement: Significantly lower in the intervention group (31.7%) compared to the control group (55%). Lung Disease Severity: Pulmonary Severity Score was significantly lower in the montelukast group on days 14 and 28. Safety Profile: No serious drug-related adverse effects were reported. Secondary Outcomes: No statistically significant differences were observed regarding mortality or length of hospital stay between the two groups. Conclusion Preventive administration of montelukast in high-risk preterm infants appears to be safe and effective in reducing the incidence of oxygen requirement at day 28/discharge.
Authors
- Zahra Vahedi (ORCID: https://orcid.org/0000-0003-4682-5502)
- Maryam Saboute (ORCID: https://orcid.org/0000-0003-2146-3752)
- Mandana Kashaki (ORCID: https://orcid.org/0000-0002-5070-8600)
- Arash Mohazzab (ORCID: https://orcid.org/0000-0002-5869-213X)
- Zahra Soltani (ORCID: https://orcid.org/0000-0003-0570-5694)
- Farhad Abolhasan Choobdar
- Majid Karoobi
- Farhad Mansoori
Institutions
- Iran University of Medical Sciences (IR)
- University of Manchester (GB)
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- Journal of Neonatal-Perinatal Medicine
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1177/19345798261509586
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00